BLCM
Bellicum Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
David M. Maggio
IPO Date
2014-12-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Bellicum Pharmaceuticals, Inc.
CEO
David M. Maggio
IPO Date
2014-12-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,941,607 |
| $0.00 |
| 24 Nov 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | X-InTheMoney | Disposed | 174,742 | $0.00 |
| 24 Nov 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | X-InTheMoney | Acquired | 174,742 | $0.00 |
| 5 May 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | Disposed | 0 | $0.00 |
| 5 May 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | Disposed | 0 | $0.00 |
| 5 May 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | Disposed | 16,159,451 | $0.00 |
| 5 May 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | Disposed | 1,531,902 | $0.00 |
| 5 May 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | Disposed | 1,531,902 | $6.50 |
| 5 May 2023 | BAKER BROS. ADVISORS LP | 10 percent owner | Disposed | 1,615,945 | $1.69 |